Silicon Laboratories is a fabless supplier of low-power wireless chips, microcontrollers, systems-on-chip and supporting software for connected industrial, commercial, home and health devices. It reports one operating segment, with revenue grouped into Industrial & Commercial and Home & Life product categories.
Loading the company summary…
A snapshot of what SILICON LABORATORIES INC. owns and owes at a point in time.
Read the company’s balance sheet in the original annual reports below.
Browse original filingsSee the original statement for its reporting period, currency, and unit.
3 reports in this collection
| Report period | Filed with SEC | Form | Source |
|---|---|---|---|
| Dec 30, 20230001104659-24-025535 | Feb 20, 2024 | 10-K | Open 10-Ksec.gov |
| Dec 28, 20240001038074-25-000003 | Feb 4, 2025 | 10-K | Open 10-Ksec.gov |
| Jan 3, 20260001038074-26-000005 | Feb 10, 2026 | 10-K | Open 10-Ksec.gov |
Dates describe the filing metadata. Figures and reporting periods should be checked against the original statement. SEC links open in a new tab.
Silicon Labs is recovering from a severe customer-inventory correction, but stronger sales have not yet restored GAAP profitability or consistently positive operating cash flow. Fiscal 2025 revenue recovered to $784.8 million, approximately its 2023 level, while higher personnel costs limited the earnings recovery. The first half of fiscal 2026 brought further revenue and margin improvement, yet inventory and receivables absorbed cash. Separately, Texas Instruments agreed to acquire eligible shares for $231 each in cash. Stockholders approved the transaction and the U.S. HSR waiting period expired, but remaining conditions still matter. For this October 24, 2026 view, the latest supplied update, dated August 11, continued to describe closing as expected in the first half of 2027—not completed. The central distinction is between improving chip economics, uneven cash conversion and a conditional acquisition outcome.
Sources: 10-K · 2026-01-03 · 10-Q · 2026-07-04 · 8-K · 2026-04-30 · 8-K · 2026-05-22
Silicon Labs combines radios, processing, security and software to help customers build connected products. Applications include smart meters, electronic shelf labels, factory and building controls, home security and medical devices. Revenue predominantly comes from chips and related products; the disclosures do not establish a material recurring software-subscription business. Industrial & Commercial and Home & Life are revenue categories, not independently profitable operating segments.
Outsourcing manufacturing limits fabrication-plant investment, but product development remains expensive: 72% of year-end 2025 employees worked in engineering. Achieving a design win can take three months to two years; the subsequent production ramp is not separately timed, and design wins may never generate expected sales. The first Series 3 product launched in 2025, but its separate revenue contribution is not disclosed.
Sources: 10-K · 2026-01-03
Revenue declined from $1.024 billion in fiscal 2022 to $782.3 million in 2023 and $584.4 million in 2024. Management attributed the downturn to customers reducing excess inventories and weak end-product demand. Fiscal 2025 revenue rebounded to $784.8 million as volumes and average prices increased. However, 2025 contained 53 weeks versus 52 in both preceding years; the additional week's contribution is unquantified.
Gross margin recovered to 58.2% from 53.4%, principally through better overhead absorption. Rising personnel costs partly offset that improvement: the operating loss narrowed to $70.5 million but remained larger than 2023's $24.2 million loss. Government incentives and declining acquired-intangible amortization supported reported expenses. These benefits do not demonstrate equivalent improvement in underlying demand or permanent cost savings.
Sources: 10-K · 2023-12-30 · 10-K · 2024-12-28 · 10-K · 2026-01-03
Fiscal 2025 operating cash flow was $95.7 million despite a $64.9 million net loss. The reconciliation included $80.3 million of stock compensation and $41.3 million from operating assets and liabilities. Capital expenditure used $29.9 million. Thus, cash generation improved, but it was neither accounting profit nor an established recurring run rate.
Year-end cash was $364.2 million, separate from $79.4 million of short-term investments. No funded borrowings remained, and no shares were repurchased in 2024 or 2025. The $400 million secured revolver is conditional borrowing capacity, not additional cash. Purchase obligations, leases, equity compensation and development spending remain relevant commitments even without borrowing debt.
Sources: 10-K · 2026-01-03
No end customer exceeded 10% of 2025 revenue, but Arrow and Edom together accounted for 49% through distribution. Most wafers came from TSMC or SMIC, with manufacturing services concentrated in Asia. Supplier replacement can take up to twelve months. Nonbinding forecasts and cancellable orders leave Silicon Labs exposed when production commitments outlast demand. The company also identifies AI-driven memory shortages at customers as a potential constraint on orders for its own chips. China shipment exposure differs materially from Chinese end-customer exposure; neither should substitute for the other.
Sources: 10-K · 2026-01-03 · 10-Q · 2026-07-04
The August 11 report showed second-quarter revenue of $228.2 million, 18.3% above the comparable quarter, and gross margin of 61.6%. Management attributed revenue growth to higher unit volumes and margin expansion to overhead absorption. The GAAP net loss narrowed to $10.6 million; the release separately reported $23.8 million of non-GAAP net income after specified exclusions.
First-half operations nevertheless used $9.6 million of cash, versus generating $53.0 million previously, as inventory and receivables increased. Cash plus short-term investments declined to $397.2 million. Management reported stronger bookings and lower customer-channel inventories, but those indicators are unquantified and distinct from rising company-owned inventory. Forward revenue and earnings guidance remains suspended because of the pending acquisition.
Sources: 10-Q · 2026-07-04 · EX-99 · 2026-08-11
The February 4, 2026 agreement, disclosed before the latest annual filing, provides $231 cash per eligible share at closing. The companies announced approximately $7.5 billion of enterprise value—not aggregate shareholder proceeds. Subsequent milestones were stockholder approval on April 30 and HSR waiting-period expiration on May 22, reported May 26. Other regulatory and contractual conditions remained. The August 11 update retained an expected first-half-2027 closing. Neither shareholder payment nor ownership transfer is established by the supplied evidence.
Sources: 8-K · 2026-02-04 · EX-99.1 · 2026-02-04 · 8-K · 2026-04-30 · 8-K · 2026-05-22 · 10-Q · 2026-07-04
USD 784.764 m
FY2025 · GAAP · consolidated · Attribution: consolidated · Reported currency · fiscal weeks: 53
| Fiscal year | Value | YoY |
|---|---|---|
| 2025 | USD 784.764 m | — |
Consolidated GAAP revenue; source amounts in thousands converted exactly to millions.
Sources: 10-K · 2026-01-03
USD 584.386 m
FY2024 · GAAP · consolidated · Attribution: consolidated · Reported currency · fiscal weeks: 52
| Fiscal year | Value | YoY |
|---|---|---|
| 2024 | USD 584.386 m | -25.3% |
| 2023 | USD 782.258 m | — |
Consolidated GAAP revenue; source amounts in thousands converted exactly to millions.
Sources: 10-K · 2026-01-03
USD -64.907 m
FY2025 · GAAP · consolidated · Attribution: consolidated · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2025 | USD -64.907 m | Loss narrowed |
| 2024 | USD -191.01 m | Loss widened |
| 2023 | USD -34.516 m | — |
Consolidated GAAP net income or loss, after income taxes and equity-method results.
Sources: 10-K · 2026-01-03
USD 95.708 m
FY2025 · GAAP · consolidated · Attribution: consolidated · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2025 | USD 95.708 m | Turned positive |
| 2024 | USD -13.91 m | Negative amount narrowed |
| 2023 | USD -30.348 m | — |
GAAP net cash provided by or used in operating activities; not net income.
Sources: 10-K · 2026-01-03
Reading times are estimates for the English text. Financial tables and charts may take additional time.
